Effect of Sglt2 Inhibitor Use in Ischemic Stroke Patients with Atrial Fibrillation without Diabetes or Heart Failure: Rationale and Design of a Randomized Controlled Trial

Lee, Meng (PI)
Chang, Jill (CoPI)
Chen, Chih Hao (CoPI)
Hsieh, Chengyang (CoPI)
Hsu, Chia Yu (CoPI)
Huang, Yen-Chu (CoPI)
Huang, Wei-Tse (CoPI)
Hung, Sung-Chun (CoPI)
Jeng, Jiann Shing (CoPI)
Lee, Jiann-Der (CoPI)
Lin, Sheng Feng (CoPI)
Liou, Chia Wei (CoPI)
Liu, Chi Hung (CoPI)
Pan, Kuo-Li (CoPI)
Pan, Wen-Yi (CoPI)
Sung, Tingyu (CoPI)
Tang, Shin Yi (CoPI)

Project: National Science and Technology Council › National Science and Technology Council Academic Grants

Abstract

對於40歲及以上無糖尿病且無心衰竭的缺血性中風伴AF患者中,如果SGLT2抑制劑加標準治療方案相比僅標準治療有更好的療效且有差不多的安全性,那這群病人除了使用直接口服抗凝劑(DOAC)等標準療法之外,加上SGLT2抑制劑能提供額外的好處。

Project IDs

Project ID:PC11307-1398
External Project ID:NSTC113-2314-B182-063

Status	Finished
Effective start/end date	01/08/24 → 31/07/25

Keywords

ischemic stroke
atrial fibrillation
SGLT2 inhibitor
nondiabetic
randomized controlled trial

Access Project

https://www.grb.gov.tw/search/planDetail?id=16561979